JP5191291B2 - 便検体中ヘモグロビンの測定方法及び測定試薬キット - Google Patents
便検体中ヘモグロビンの測定方法及び測定試薬キット Download PDFInfo
- Publication number
- JP5191291B2 JP5191291B2 JP2008175668A JP2008175668A JP5191291B2 JP 5191291 B2 JP5191291 B2 JP 5191291B2 JP 2008175668 A JP2008175668 A JP 2008175668A JP 2008175668 A JP2008175668 A JP 2008175668A JP 5191291 B2 JP5191291 B2 JP 5191291B2
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- antibody
- haptoglobin
- carrier
- measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010054147 Hemoglobins Proteins 0.000 title claims description 97
- 102000001554 Hemoglobins Human genes 0.000 title claims description 97
- 238000000034 method Methods 0.000 title claims description 63
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 46
- 238000005259 measurement Methods 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 230000008859 change Effects 0.000 claims description 30
- 238000000691 measurement method Methods 0.000 claims description 28
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 26
- 238000002835 absorbance Methods 0.000 claims description 24
- 230000003287 optical effect Effects 0.000 claims description 18
- 239000004816 latex Substances 0.000 claims description 15
- 229920000126 latex Polymers 0.000 claims description 15
- 230000004520 agglutination Effects 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 230000001900 immune effect Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 44
- 102000014702 Haptoglobin Human genes 0.000 description 42
- 108050005077 Haptoglobin Proteins 0.000 description 42
- 239000000523 sample Substances 0.000 description 42
- 238000010790 dilution Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 18
- 239000000872 buffer Substances 0.000 description 13
- 238000011481 absorbance measurement Methods 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 9
- 238000004220 aggregation Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 238000007865 diluting Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 239000006173 Good's buffer Substances 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 238000011005 laboratory method Methods 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002683 reaction inhibitor Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 229920001342 Bakelite® Polymers 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 101001078385 Homo sapiens Haptoglobin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000023505 abnormal feces Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 108010071602 haptoglobin-hemoglobin complex Proteins 0.000 description 2
- 102000050796 human HP Human genes 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 201000007637 bowel dysfunction Diseases 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008175668A JP5191291B2 (ja) | 2008-07-04 | 2008-07-04 | 便検体中ヘモグロビンの測定方法及び測定試薬キット |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008175668A JP5191291B2 (ja) | 2008-07-04 | 2008-07-04 | 便検体中ヘモグロビンの測定方法及び測定試薬キット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010014586A JP2010014586A (ja) | 2010-01-21 |
| JP2010014586A5 JP2010014586A5 (enExample) | 2011-07-21 |
| JP5191291B2 true JP5191291B2 (ja) | 2013-05-08 |
Family
ID=41700826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008175668A Active JP5191291B2 (ja) | 2008-07-04 | 2008-07-04 | 便検体中ヘモグロビンの測定方法及び測定試薬キット |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5191291B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5877150B2 (ja) * | 2010-03-31 | 2016-03-02 | 積水メディカル株式会社 | 多価抗原測定用コンジュゲートを製造する方法 |
| JP5861977B2 (ja) | 2014-06-18 | 2016-02-16 | 関根 弘一 | 大便色検知装置 |
| ES2985318T3 (es) | 2016-05-30 | 2024-11-05 | Eiken Chemical | Anticuerpo monoclonal anti hemoglobina humana o kit de anticuerpos, partícula portadora insoluble en la que se inmoviliza el anticuerpo monoclonal anti hemoglobina humana, reactivo de medición y método de medición usando el mismo |
| CN112752974A (zh) * | 2018-09-26 | 2021-05-04 | 荣研化学株式会社 | 血红蛋白的测定试剂、测定试剂盒和测定方法 |
| CN118883926A (zh) * | 2024-07-10 | 2024-11-01 | 山东艾科达生物科技有限公司 | 一种超敏大便潜血检测试剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02193071A (ja) * | 1989-01-20 | 1990-07-30 | Green Cross Corp:The | ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法 |
| JPH07103978A (ja) * | 1993-09-30 | 1995-04-21 | Wakamoto Pharmaceut Co Ltd | 遊離ヘモグロビン測定 |
| JPH10132824A (ja) * | 1996-10-28 | 1998-05-22 | Eiken Chem Co Ltd | ヘモグロビンの安定化方法 |
| JPH11201969A (ja) * | 1998-01-14 | 1999-07-30 | Wakamoto Pharmaceut Co Ltd | 簡易遊離ヘモグロビン測定方法および測定用キット |
| JP4261665B2 (ja) * | 1999-03-05 | 2009-04-30 | アルフレッサファーマ株式会社 | 溶液中のヒトヘモグロビンの安定化方法および安定化溶液 |
-
2008
- 2008-07-04 JP JP2008175668A patent/JP5191291B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010014586A (ja) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6172163B2 (ja) | 検体中のヘモグロビンＡ１ｃの免疫測定方法 | |
| JP7184054B2 (ja) | 測定試料希釈液およびキットおよび測定方法 | |
| JP7508494B2 (ja) | ヘモグロビンの測定試薬、測定キット及び測定方法 | |
| JP5735615B2 (ja) | 免疫学的測定における感度増強方法及びそのための試薬 | |
| JP5191291B2 (ja) | 便検体中ヘモグロビンの測定方法及び測定試薬キット | |
| JP4704662B2 (ja) | 免疫学的ラテックス比濁分析方法及びその試薬 | |
| JPWO2001092885A1 (ja) | 免疫学的ラテックス比濁分析方法及びその試薬 | |
| JPH06300761A (ja) | 免疫比濁測定試薬及び測定方法 | |
| WO2002048711A1 (en) | Immunological assay reagents and assay method | |
| JP5088471B2 (ja) | 標的物質の検出方法およびラテックス凝集反応用試薬 | |
| JP3266960B2 (ja) | 金コロイド粒子を用いた免疫分析法 | |
| JP5426661B2 (ja) | 免疫分析方法及びそのための試薬 | |
| JP2000258420A (ja) | 溶液中のヒトヘモグロビンの安定化方法および安定化溶液 | |
| JPH02257063A (ja) | 免疫測定試薬および免疫測定法 | |
| JPH1123573A (ja) | 免疫学的測定方法 | |
| TW202022344A (zh) | 測定試樣稀釋液 | |
| JP2004191332A (ja) | 免疫学的分析試薬及び免疫学的分析方法 | |
| WO2021153127A1 (ja) | 免疫検査方法 | |
| JP3464357B2 (ja) | 免疫学的凝集反応試薬の製造方法 | |
| JP2006194746A (ja) | 被測定物質測定方法及び免疫測定用試薬 | |
| JP2006071574A (ja) | 免疫比濁法及びそのための試薬 | |
| JP2885092B2 (ja) | Ｃ反応性タンパク質の測定法及び測定試薬 | |
| JP3423085B2 (ja) | 免疫測定法 | |
| JP2011133285A (ja) | アレルギー検査方法 | |
| TW201932838A (zh) | 將血紅素與血紅素結合球蛋白之複合體安定化之方法、及用以保存含有血紅素之檢體之保存溶液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110606 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110606 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120613 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120619 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120817 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130115 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130129 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5191291 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160208 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |